Clinical isolates of the fungal human pathogen Candida albicans are invariably diploid and heterozygous, impeding genetic study. Recent isolation of C. albicans haploids opens opportunities to apply technologies unfeasible in diploids. However, doubts remain on whether the haploids, derived from chromosome loss, can represent the diploids. Here, we use C. albicans haploids to investigate biofilm, a key virulence attribute. We conducted the first comprehensive characterization of biofilm formation of the haploids in comparison with the diploids. We demonstrate that the haploids form biofilms with essentially the same characteristics as the diploids. Screening a haploid mutant library has uncovered novel GTPase-related genes as biofilm regulators, including IRA2 that encodes an activator of the Ras GTPase. IRA2-deletion mutants develop poorly constructed biofilm in both haploid and diploid C. albicans. Our results demonstrate that the haploids are a valid model for C. albicans biofilm research and a powerful tool for uncovering novel regulators.
Historically, C. albicans was regarded as an obligate diploid organism with no haploid state 6, 7 . Hickman et al recently discovered haploid strains of C. albicans 8 . This ground-breaking discovery has a profound impact on the current understanding of C. albicans biology and pathogenicity. In addition, the availability of C. albicans haploid immediately offers high promise to enable, for the first time, applying powerful genetic and molecular approaches previously very difficult or impossible to do in diploid cells 9 . However, as the haploid strains were generated through loss of one set of chromosomes from a highly heterozygous diploid parent, many recessive mutations are unmasked resulting in a genetic background different from their parent. Indeed, the haploid strains show reduced growth rate and diminished virulence compared to their diploid parent, although they do exhibit several key characteristics defining this species, such as the yeast-hyphae transition, the white-opaque switching, and chlamydospore formation 8 . These issues have raised doubts on the suitability of using the haploid strains as research tools, because findings derived from the haploid may not be reproduced in the diploid.
In this work, we performed proof-of-concept experiments. We first comprehensively compared C. albicans haploid and diploid strains for their ability to form biofilm, a trait of high importance for life-threatening systemic infection but yet uncharacterized in C. albicans haploid. We then constructed a haploid gene-deletion library for genes encoding uncharacterized GTPases and their regulators, and screened the library to look for novel regulators of biofilm formation. We found that the haploid strains are fully capable of forming biofilms, albeit at a slower rate compared to the diploid strains. The haploid biofilm matured and reached a comparable level to the diploid biofilm after three days. The matured haploid biofilm exhibited essentially the same compositional and architectural characteristics as the diploid biofilm. In addition, by screening the haploid mutant library, we identified IRA2 as a novel positive regulator of biofilm development in both C. albicans haploids and diploids. This study, therefore, demonstrates that C. albicans haploids can serve as a valid model for the study of biofilm formation and for rapid identification of novel gene functions.
Results

C. albicans haploid forms biofilm in vitro.
To determine whether C. albicans haploids can serve as a valid model to study biofilm formation, we carried out the first comprehensive characterization of C. albicans haploid biofilms in comparison to their diploid counterparts. We assessed the biofilm forming ability of two haploid strains, GZY792 and GZY803 8 , and two common laboratory diploid strains, SC5314 and BWP17. These strains were cultured according to the published protocol 10 to allow the development of biofilm. The biofilms formed by each strain were then quantified at 24 h intervals by both the XTT reduction assay (Fig. 1a) and colony forming unit (CFU) counting method (Fig. 1b) . The haploid strains were capable of forming mature biofilm communities albeit at a slower rate compared to the diploids (Fig. 1a,b) . At 24 h after initial adhesion, haploid cells grew and expanded into microcolonies, and appearance of extracellular materials (ECM) was observed at 48 h. For the diploid strains, ECM was observed at 24 h (Fig. 1c) . Scanning electron microscopy (SEM) and confocal laser scanning microscopy (CSLM) imaging revealed that haploid strains demonstrated mature biofilm architecture by 72 h, whereas diploid strains exhibited the same by 48 h (Fig. 1d,e) . Mature haploid biofilms and diploid biofilms were structurally similar with spatial arrangements of yeast and hyphal cells embedded in ECM giving the classical three-dimensional appearance of C. albicans biofilms. The biofilm comprised of stacks of yeast and hyphal cells with 10-20 μ m in height, supported by extracellular matrix, although diploid biofilms contained more hyphal cells by 24 h than haploid biofilms (Fig. 1c-e) . We also measured the height of biofilms formed by haploid and diploid strains at different time points. At 24 and 48 h, the average heights of haploid biofilms were substantially less than those of the diploid biofilms. However, the haploid strains could construct biofilms by 72 h with an average height around 13 μ m, which was comparable with that of diploid biofilms (Fig. 1f) . Taken together, we conclude that the haploid strains are capable of forming biofilms characteristic of the diploid biofilm in vitro.
C. albicans haploid maintains its ploidy during biofilm formation. C. albicans haploids are naturally unstable and tend to auto-diploidize under various culture conditions 8 . Although the haploid tool strains (GZY792 and GZY803) we used for biofilm formation are substantially stable to sustain molecular genetic manipulations 8, 9 , it remains unclear whether they are also stable during biofilm formation. To address this issue, we took biofilm samples as well as the dispersed cells at different time points during the haploid biofilm development for ploidy assessment by flow cytometry (Fig. 2a-d) . Both biofilm and dispersed cells of GZY792 and GZY803 maintained the haploid state during the whole course of biofilm formation (up to 96 h), indicating that the C. albicans haploid tool strains are stable in ploidy during the development of biofilms.
C. albicans haploids form biofilm ex vivo. In order to ascertain the comparative biofilm formation ability, reconstituted human oral epithelial (RHOE) model was used to examine the ex vivo biofilm formation of haploid GZY803 cells in comparison to diploid SC5314 cells (Fig. 3) . Consistent with the observations on in vitro biofilm formation, the haploid strain was able to form comparable biofilms on RHOE, albeit at a slower rate compared to the diploid strain. The diploid strain formed a thick layer of mature biofilm on the oral epithelial surface by 48 h, whereas the haploid strain formed the same by 72 h. Fungal invasion into the tissues could be detected as early as in 24 h biofilm, which was more obvious Screen of a haploid mutant library for new biofilm regulators. Next, we utilized this novel haploid C. albicans biofilm model to identify novel regulators of biofilm formation. GTPases are modulators of hyphal formation in C. albicans 11, 12 , which could influence biofilm forming ability 13 . However, little is known about the role of GTPases in regulating C. albicans biofilm formation. Our group recently established an efficient protocol to rapidly generate specific gene knock out mutants in C. albicans haploids 9 , which greatly facilitates the discovery of novel gene functions. Using this new methodology, we constructed from the haploid strain GZY803 a gene-deletion library for 35 putative GTPases and GTPase regulators with unknown functions and screened the mutants for defects in biofilm formation using the newly established haploid biofilm model. Biofilm was allowed to develop in GMM medium supplemented with required amino acids at two different temperatures, 30 °C and 37 °C, to select temperature-independent regulators from the mutant library. Biofilm formation was evaluated by XTT assay at 72 h after initial adhesion, since the parental haploid strain (GZY803) and most diploid strains 5 were capable of forming mature biofilm by 72 h. Readings taken for biofilms formed by each mutant was normalized to the parent strain GZY803. Foregoing experiments revealed that deletion of IRA2, ARL1, LRG1, AGE2 or the uncharacterized ORF19.3216 gene significantly affected the biofilm formation in a temperature-independent manner (Fig. 4) . Interestingly, deletion of IRA2 or ORF19.3216 had inhibitory effect on biofilm formation while deletion of ARL1, LRG1, AGE2 seemed to promote the development of biofilm. Similar results were obtained when biofilm was allowed to develop in RPMI, another medium commonly used for C. albicans studies (Fig. S1 ), suggesting that the observed phenotypes are independent of the culture medium.
Confirmation of IRA2 as a biofilm regulator in C. albicans haploids. Ira2 is a putative
GTPase-activating protein of Ras1, an activator of the cAMP/protein kinase A pathway that critically controls the hyphal growth and biofilm formation. However, the function of C. albicans IRA2 has not been characterized in details, although a previous study had demonstrated that the ira2Δ/Δ is not defective in both yeast and hyphal growth 14 . We found that the ira2Δ haploid mutant has a similar growth rate like its wild-type parent (GZY803) under biofilm culture conditions (Fig. S2a) . In agreement with Reconstituted human oral epithelia were infected with the diploid SC5314 and haploid GZY803, respectively, and incubated at 37 °C with 5% CO 2 . Samples were taken at the time points as indicated and processed for acid-Schiff staining to visualize C. albicans biofilm formation and tissue invasion. the previous study 14 , the ira2Δ haploid mutant is also not defective in morphogenesis as it exhibited normal yeast cell morphology and produced hyphae indistinguishable from those of the wild-type parent at 37 °C upon serum induction (Fig. S2b) . These findings suggest that IRA2 might have a direct role in regulating biofilm formation instead of acting indirectly via the Ras pathway that regulates the hyphal development. To confirm that IRA2 is a biofilm regulator in the haploid context, we examined the biofilm formation of both ura + ira2Δ (GZY893) and ura -ira2Δ (GZY918) strains at 24 h, 48 h, and 72 h relative to their parental strain GZY803 and a rescued strain GZY941. Strikingly, at the mature stage of biofilm formation (72 h), both ira2∆ strains exhibited about 10-fold reduction in CFU compared to the parental strain, which is consistent with the results of the XTT reduction assay (Fig. 5a,b) . SEM and CSLM imaging showed that the ira2∆ strains formed a meagre biofilm, being thinner and less dense than the biofilm formed by the parental strain (Fig. 5c,d ). Estimation of biofilm average height from CSLM was also consistent with the findings (Fig. 5e) . When a wild-type copy of IRA2 was reintroduced into the ira2∆ mutant, the resulting rescued strain (GZY941) largely restored the biofilm formation features of the haploid strain as demonstrated by XTT, CFU and CSLM results (Fig. 5a-e) , suggesting that the biofilm formation defects observed in ira2∆ mutants are indeed due to the loss of IRA2 gene function. Consistently, the RHOE model also showed a significantly reduced ability of the ira2∆ strain to form biofilm in comparison with the rescued strain (Fig. 5f ). This comprehensive set of data firmly established an important regulatory role for IRA2 in regulating biofilm formation in C. albicans haploids. ira2∆/∆ mutant (GZY921) from the diploid strain BWP17 for biofilm formation assays. Previous studies have established BCR1 as a key biofilm regulator since the bcr1∆/∆ mutant only shows defects in biofilm formation but not in hyphal morphogenesis 15 . Therefore, we included bcr1∆ haploid (GZY1095) and bcr1∆/∆ diploid (GZY1094) mutants as controls in the experiments. Our XTT and CFU results reflected a consistent observation of the biofilm formation between haploid and diploid mutants (Fig. 6 ). Both bcr1∆ haploid and bcr1∆/∆ diploid strains were defective in forming mature biofilm, thus serving as good negative controls. Similarly, ira2∆ haploid and ira2∆/∆ diploid strains both showed a reduction in biofilm formation compared to the haploid GZY803 or diploid BWP17 parental strains, respectively. Again, the defective biofilm formation of ira2 haploid and diploid mutants could be largely rescued by re-integration of a wild-type IRA2 gene back to the mutants, further confirming the important role of IRA2 in biofilm formation. In summary, our results demonstrate that the C. albicans haploid strains we developed are powerful tools in the discovery of novel regulators of traits as complex as biofilm formation in this fungal pathogen of humans.
Discussion
The discovery of C. albicans haploids was revolutionary, as this fungus had long been thought to be an obligate diploid 6, 7 . And, the diploid nature of this organism has impeded application of some powerful genetic approaches routinely used in organisms with a haploid phase in their life cycle 16 , thus greatly hindering progress in C. albicans research. There have been doubts on using the haploids to study C. albicans, because the haploids carry many unmasked recessive mutations compared to their diploid parent. In this study, we demonstrate the successful use of C. albicans haploids to discover new regulators of biofilm formation. We performed the first detailed characterization of C. albicans haploid biofilms, and then used the haploids in genetic screens to find novel regulators.
We developed and characterized C. albicans haploid biofilms using two models. One was an in vitro model using multi-well tissue culture plates, and the other was the ex vivo RHOE model which is known to simulate clinical conditions 17 . We observed that the haploid strains followed the same stages as the diploids to develop mature biofilms (Fig. 1) , and were able to stably maintain their ploidy during the Figure 6 . Quantification of biofilms formed by haploid ira2Δ and diploid ira2Δ/Δ mutants. The biomass of biofilms formed in vitro by haploid ira2Δ (GZY893) and its rescued strain (ira2Δ+IRA2, GZY941), as well as diploid ira2Δ/Δ (GZY921) and its rescued strain (ira2Δ/Δ+IRA2, GZY1022) were quantified with XTT reduction assay (a) and CFU counting (b). GZY803 with bcr1Δ (GZY1095), and BWP17 with bcr1Δ/Δ (GZY1094), were used as the positive and negative controls for haploid and diploid, respectively. Cells were cultured at 30 °C overnight and re-inoculated to allow the development of biofilm at 37 °C for 72 h. whole course of biofilm development (Fig. 2) . The only difference was that the haploids showed less initial adhesion to the substrate and needed more time to reach a stable mature biofilm community. For most C. albicans diploid strains, microcolony formation, sign of early biofilm development stage, is at 3-4 h 5 . Intermediate biofilm development, marked by the emergence of early extracellular material, is at 12 h after initial adhesion. Maturation of diploid biofilm is observed at 38-72 h 5 . The C. albicans haploid cells developed the microcolony and intermediate biofilm at 24 h and 48 h, respectively, later than the diploid strains. Nevertheless, the haploid biofilm still reached the mature stage at 72 h. The mature haploid biofilm comprised of metabolically active cells encased in extracellular materials (Fig. 1) . This level of complexity in terms of yeast and hyphal architecture of the haploid biofilms was comparable to that of mature diploid biofilms.
RHOE is a well-recognized model for the study of host-microbial interaction and oral candidiasis 17, 18 . Corroborating the results of the in vitro model, the haploid strains formed comparable biofilms to that of diploids on the epithelium at 72 h (Fig. 3) . However, we noted a delay in tissue invasion by the haploid cells. The diploid cells had invaded the epithelia by 24 h, whereas the haploid cells showed no clear invasion until 48 h. This indicates that the haploid strain is capable of invading the epithelium in spite of some delay. The delay is probably attributable to the decreased adhesion properties and slower growth of the haploid cells than the diploids 19 . Overall, despite slower development in early stages, the haploid strains eventually formed mature biofilms exhibiting essentially the same cell composition and architecture as the biofilms formed by the diploid strains. Also, we did not detect autodiploidization in the process of haploid biofilm formation (Fig. 2) . Thus, our results demonstrate that C. albicans haploid strains can be utilized to assess phenotypic features in mature biofilms under appropriate experimental settings.
GTPases are molecular switches involved in the regulation of numerous biological processes. In C. albicans, small GTPases such as Cdc42 and Ras1 have been extensively investigated for their roles in regulating hyphal growth and tissue invasion 11, 12, [20] [21] [22] [23] . To unravel novel gene functions, we have constructed a haploid gene-deletion library covering mostly genes encoding uncharacterized GTPases and their regulators listed in the Candida Genome database (manuscript in preparation). To identify new regulators of biofilm formation in C. albicans, we made use of this library to screen for mutants exhibiting altered ability for biofilm formation in this study. Initial screening revealed that deletion of IRA2, LRG1, ARL1, AGE2 or ORF19.3216 in the haploid significantly affected biofilm formation at both 30 and 37 °C (Fig. 4) . None of these genes have been characterized in C. albicans, although some of their homologues have been studied in other fungi such as Saccharomyces cerevisiae (Sc). ScIRA2 encodes a GTPase-activating protein (GAP) that negatively regulates the small GTPase Ras2 which activates the cAMP/protein kinase A (PKA) pathway 24 . C. albicans has two Ras proteins, Ras1 and Ras2, that play antagonistic roles in regulating the cAMP/PKA pathway 25 which governs both hyphal growth and biofilm development [26] [27] [28] . Furthermore, ScIRA2 is a key modulator for cellular response against heat shock, starvation, and dormant cell formation 24, 29 . The observed involvement of IRA2 in biofilm formation may help to explain the molecular mechanism underlying the tolerance of C. albicans biofilm against extreme conditions. ScLRG1 encodes a GAP of Rho1 involved in negative regulation of the Pkc1-mediated cell wall integrity signaling pathway 30 , but its role in biofilm has not been examined. ScARL1 encodes a soluble GTPase having a role in regulation of membrane trafficking 31 , and ScAge2 is an ADP-ribosylation factor GAP effector playing a part in Trans-Golgi-Network transport 31, 32 . Our observations suggest that membrane trafficking may have an important role in biofilm development 33 . Consistently, the cAMP pathway activates directional membrane trafficking during hyphal development 34, 35 which is required for biofilm formation in C. albicans 36 
.
To confirm that IRA2 is indeed required for proper biofilm formation, we used two biofilm models and a range of assays, including XTT reduction assay, CFU counting, microscopic imaging and analysis, and confocal computational analysis, to assess biofilm formation of the haploid ira2Δ mutant. The results consistently demonstrated defective biofilm formations in the mutant, which could be rescued by reintroducing a copy of wild-type IRA2 back to the mutant (Fig. 5) . When we deleted both copies of IRA2 in the diploid BWP17 strain, the same defects on biofilm formation were also observed in the diploid ira2Δ/Δ mutant (Fig. 6) , suggesting that the biofilm defects of the haploid ira2Δ mutant is directly attributed to IRA2 gene function rather than a phenotype peculiar to the genetic background of the strain. This comprehensive set of data indicates that IRA2 plays an important role in the regulation of C. albicans biofilm formation.
In addition to ira2Δ, four other mutants (orf19.3216Δ, arl1Δ, lrg1Δ, age2Δ) have also been found to significantly affect C. albicans biofilm formation in the initial screening assays (Fig. 4) . The enhanced biofilm formation of arl1Δ and lrg1Δ mutants might be due to their abnormal morphogenesis during yeast and/or hyphal growth (Fig. S2b) , while the enhanced biofilm formation of age2Δ at 37 °C is likely a result of its accelerated growth rate (Fig. S2a) . Interestingly, the orf19.3216Δ mutant shows a similar growth rate as the wild-type parental strain at both 30 °C and 37 °C, and exhibits normal yeast and hyphal morphologies (Fig. S2 ), rendering it a good candidate of another previously unknown biofilm regulator. However, the roles of these genes in regulating C. albicans biofilm formation remains to be further investigated.
In summary, we have demonstrated that in spite of genetic differences, C. albicans haploids can be used as a valid model for the study of complex traits, such as biofilm formation, that characterize C. albicans diploids. Importantly, the feasibility to carry out genetic screens using the haploid strains can greatly accelerate discovery of new genes or pathways and speed up identification of novel antifungal drug targets.
Methods
Strains, plasmids, and growth conditions. Construction of yeast strains and plasmids used in this study are described in Supplemental Table 1 and 2, respectively. Recombinant DNA manipulations were performed according to standard methods. E.coli XL1 blue (Stratagene) was used as the host strain for recombinant plasmids and cultured in LB broth (0.5% yeast extract, 1% tryptone, and 0.5% NaCl, pH 7.0) supplemented with ampicillin (100 μ g/ml). Transformation of C. albicans was performed according to the protocol of the Fast Yeast Transformation Kit (G-Biosciences). Targeted gene deletion was performed by transforming the host cells with gene deletion cassette and verified by colony PCR as described 9 . Loop out of URA3 via FLP-mediated excision followed the previous protocols 37 . Yeast cells were routinely grown at 30 °C in YPD (2% yeast extract, 1% peptone, and 2% glucose), or GMM (glucose minimal medium, 6.79 g/l yeast nitrogen base without amino acids, and 2% glucose) supplemented with appropriate amino acids (uridine 80 μ g/ml, arginine 40 μ g/ml, and histidine 40 μ g/ml) and 5-FOA (1 mg/ml) when necessary. Solid medium plates were prepared by the addition of 2% agar.
In vitro biofilm development. A single colony of each yeast strain was inoculated into GMM medium (supplemented with required amino acids) and grown at 30 °C overnight. The biofilm was developed according to a previous published protocol 10 . In brief, cell suspension was prepared in GMM (supplemented with required amino acids) with the overnight culture at MacFarland standard 0.375 (equivalent to 10 7 cells/ml). Aliquots of 100 μ l of cell suspension were transferred into wells of pre-sterilized flat-bottomed 96-well microtiter plates (Greiner bio-one). The plates were incubated at 30 °C or 37 °C (depending on the nature of the experiment) for 1.5 h with a shaking speed of 80 rpm. After this adhesion phase, non-adhered cells were removed and the adhered cells were replenished with 200 μ l of fresh GMM (supplemented with required amino acids). The plates were incubated under the same conditions for up to 96 h, and dispersed cells and biofilm samples were taken every 24 h for evaluation using standard methodologies.
Biofilm quantification. The biofilm was quantified using 2, 3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay and colony forming unit (CFU) counting method. After culture medium was aspirated, biofilms were washed with 100 μ l of phosphate buffered saline (PBS) once to remove non-adhered cells. XTT assay was performed according to a previously optimized protocol 10 . Briefly, biofilms were incubated with XTT solution (containing 4 μ M menadione and 0.2 mg/ml XTT in PBS) at 37 °C and kept in dark for 20 min. The solutions were transferred to a new plate and colorimetric changes were measured at 490 nm using a calibrated spectrophotometer (Multiskan ™ GO, Thermo Scientific). In parallel, some biofilms were taken for enumeration of cells by CFU counting method as previously described 38 . Dilution series were prepared from the biofilm suspensions and colonies were counted after incubation at 30 °C for 2 days.
Ex vivo biofilm development. C. albicans biofilm formation on ex vivo reconstituted human oral epithelium (RHOE) was performed as described previously 39 . Upon arrival, the RHOE was transferred to a 24-multiwell plate (Nunc). The tissues was recovered by incubating at 37 °C overnight in serum-free, chemically defined medium MCDB 153 (Skinethic Laboratory) containing 5 mg/ml insulin, 1.5 mM CaCl 2 , 25 mg/ml gentamicin and 0.4 mg/ml hydrocortison. The tissues was then infected with 200 μ l of 10 8 cells/ml C. albicans cells in GMM medium and incubated at 37 °C in 5% CO 2 for up to 72 h. Samples were harvested at desired time points, washed gently to remove non-adherent C. albicans cells and fixed in 4% paraformaldehyde (Sigma) in PBS for 1 h at room temperature. The fixed tissues were then taken and processed for acid-Schiff (PAS) staining to visualize the C. albicans biofilm formation and tissue invasion.
Scanning electron microscopy. Scanning electron microscopy was used to examine the topographic features of the C. albicans biofilms formed on coverslips (Thermo Scientific) under similar environmental conditions as described above. The biofilms on coverslips were washed with PBS once and fixed with 2.5% glutaraldehyde (Sigma) overnight at 4 °C. The coverslips were osmicated with 1% osmium tetraoxide for 30 min and dehydrated with a series of ethanol alcohol (70% for 1 h, 95% for 10 min and 100% for 10 min). Coverslips were air dried in a desiccator prior to sputter coating with gold. Afterwards, specimens were mounted on the aluminium stubs and coated with gold in a low-pressure atmosphere with an ion sputter coater (JFC1 100, Jeol). The topographic features of the biofilm were visualized with a scanning electron microscope (Philips XL30CP).
Confocal laser scanning microscopy. C. albicans biofilms were developed on Thermanox (Nunc) Fluoview FV1000 TIRF confocal microscope. Z-sections were collected. Images were analysed using Olympus FV10-ASW Viewer and Fiji software 40 . Estimation of the biofilm biovolume was supported by bioImage_L developed by Chávez de 41 . Extracellular matrix staining. C. albicans biofilms were developed on 8 well chamber glass (Nunc) as described above and samples were taken at different time point. The cells were stained with Concanavalin-Alexa Flour ® 488 (Green) (Invitrogen, 100 μ g/ml in PBS) by incubating in dark for 20 min as described 5 . The images were taken with an Olympus Fluoview FV1000 TIRF confocal microscope. Z-sections were collected. Images were analysed using Olympus FV10-ASW Viewer and Imaris software (Bitplane).
